Cargando…
Pre-emptive pharmacological inhibition of fatty acid–binding protein 4 attenuates kidney fibrosis by reprogramming tubular lipid metabolism
Kidney fibrosis is a hallmark of chronic kidney disease (CKD) progression that is caused by tubular injury and dysregulated lipid metabolism. Genetic abolition fatty acid-binding protein 4 (FABP4), a key lipid transporter, has been reported to suppress kidney interstitial fibrosis. However, the role...
Autores principales: | Chen, Yuting, Dai, Yue, Song, Kaixin, Huang, Yi, Zhang, Le, Zhang, Cuntai, Yan, Qi, Gao, Hongyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8175732/ https://www.ncbi.nlm.nih.gov/pubmed/34083513 http://dx.doi.org/10.1038/s41419-021-03850-1 |
Ejemplares similares
-
Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis
por: Chen, Yuting, et al.
Publicado: (2020) -
Inhibition of ACSL4 ameliorates tubular ferroptotic cell death and protects against fibrotic kidney disease
por: Dai, Yue, et al.
Publicado: (2023) -
Regional blocks for pre-emptive anti-emesis
por: Gupta, Deepak
Publicado: (2012) -
Pre-emptive genomic surveillance of emerging ebolaviruses
por: Postigo-Hidalgo, Ignacio, et al.
Publicado: (2020) -
Adding pre-emptive anticholinergics to antipsychotics: Is it justified?
por: Chatterjee, Kaushik, et al.
Publicado: (2022)